BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25373500)

  • 1. Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII).
    Scozzafava A; Passaponti M; Supuran CT; Gülçin İ
    J Enzyme Inhib Med Chem; 2015; 30(4):586-91. PubMed ID: 25373500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII).
    Scozzafava A; Kalın P; Supuran CT; Gülçin İ; Alwasel SH
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):941-6. PubMed ID: 25586344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with secondary sulfonamides incorporating benzothiazole scaffolds.
    Petrou A; Geronikaki A; Terzi E; Guler OO; Tuccinardi T; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1306-11. PubMed ID: 26745009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII.
    Nocentini A; Ceruso M; Carta F; Supuran CT
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1226-33. PubMed ID: 26681367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I and II, and extracellular isoforms IV, IX, and XII with sulfamides incorporating sugar moieties.
    Colinas PA; Bravo RD; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5086-90. PubMed ID: 17658252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
    Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mammalian carbonic anhydrase isoforms I-XIV with a series of phenolic acid esters.
    Maresca A; Akyuz G; Osman SM; AlOthman Z; Supuran CT
    Bioorg Med Chem; 2015 Nov; 23(22):7181-8. PubMed ID: 26498394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation.
    Moi D; Nocentini A; Deplano A; Balboni G; Supuran CT; Onnis V
    Eur J Med Chem; 2019 Nov; 182():111638. PubMed ID: 31472471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.
    Innocenti A; Gülçin I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5050-3. PubMed ID: 20674354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Schiff base derivatives of 4-(2-aminoethyl)-benzenesulfonamide with inhibitory activity against carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2377-81. PubMed ID: 25913118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z; Sławiński J; Vullo D; Supuran CT
    Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
    Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII.
    D'Ascenzio M; Carradori S; De Monte C; Secci D; Ceruso M; Supuran CT
    Bioorg Med Chem; 2014 Mar; 22(6):1821-31. PubMed ID: 24560739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.